ALAB Astera Labs, Inc. - Common Stock
$264,50
Cena · Maj 20, 2026
Dane fundamentalne na dzień Maj 6, 2026
Zakres 52 tyg.
$85–$269
98% of range
Ocena Analityków
BUY
30 analysts
Cena Docelowa
$243
P/E (TTM)
136.4
ROE
17.5%
Marża Zysku Netto
25.7%
ALAB Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$264.50
Kapitalizacja Rynkowa
$28.31B
P/E (TTM)
136.4
EPS (TTM)
$1.22
Przychody (TTM)
$853M
Stopa dywidendy
—
ROE
17.5%
D/E Dług/Kapitał
—
Zakres 52 tyg.
$85 – $269
ALAB Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Configure
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody i Zysk Netto
$853M
2022-12-31
→
2025-12-31
EPS
$1.22
2022-12-31
→
2025-12-31
Wolny przepływ pieniężny
$282M
2024-12-31
→
2025-12-31
Marże
25.7%
2024-12-31
→
2025-12-31
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
Wskaźnik
Trend 5-letni
ALAB
Mediana porównawcza
P/E (TTM)
136.4
45.7
P/S (TTM)
33.2
11.3
P/B
20.8
7.2
Price / FCF (Cena / FCF)
100.5
—
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
Wskaźnik
Trend 5-letni
ALAB
Mediana porównawcza
Gross Margin (Marża brutto)
75.7%
54.4%
Operating Margin (Marża Operacyjna)
20.3%
—
Net Profit Margin (Marża Zysku Netto)
25.7%
16.5%
ROA
17.0%
7.2%
ROE
17.5%
10.3%
ROIC
12.8%
—
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
Wskaźnik
Trend 5-letni
ALAB
Mediana porównawcza
Current Ratio (Wskaźnik bieżący)
10.2
3.5
Quick Ratio (Wskaźnik Szybkości)
1.9
—
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
Wskaźnik
Trend 5-letni
ALAB
Mediana porównawcza
Revenue YoY (Przychody R/R)
115.1%
—
Revenue CAGR 3Y (Przychody CAGR 3L)
120.2%
—
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
Wskaźnik
Trend 5-letni
ALAB
Mediana porównawcza
ALAB Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
KUP
30 analityków
- Mocne kupno 7 23,3%
- Kup 16 53,3%
- Trzymaj 7 23,3%
- Sprzedaj 0 0,0%
- Mocna sprzedaż 0 0,0%
12-miesięczny cel cenowy
22 analityków · 2026-05-19
Mediana
$257.50
Średnia
$242.51
Teraz
$264.50
Niski
$153.32
Wysoki
$297.00
Średni cel
$257.50
-2,6%
Średnia cel
$242.51
-8,3%
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
0.07%
| Okres | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|
| 31 marca 2026 | $0.61 | $0.55 | 0.06% |
| 31 grudnia 2025 | $0.58 | $0.52 | 0.06% |
| 30 września 2025 | $0.49 | $0.40 | 0.09% |
| 30 czerwca 2025 | $0.44 | $0.33 | 0.11% |
| 31 marca 2025 | $0.33 | $0.29 | 0.04% |
Porównanie jednostek Kluczowe metryki w porównaniu do konkurentów z sektora
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| ALAB | $28.31B | 136.4 | 115.1% | 25.7% | 17.5% | 75.7% |
| MPWR | $44.15B | 70.5 | 26.4% | 22.3% | 18.0% | 55.2% |
| MCHP | $26.08B | -4841.0 | -42.4% | -0.01% | -0.01% | 56.1% |
| MRVL | $68.75B | 26.4 | 42.1% | 32.6% | 19.3% | 51.0% |
| ON | $21.48B | 186.7 | -15.3% | 2.0% | 1.5% | 33.1% |
| GFS | — | — | — | — | — | — |
| MTSI | $9.49B | -174.5 | 32.6% | -5.6% | -4.3% | 54.7% |
| FSLR | $28.03B | 18.4 | 24.1% | 29.3% | 16.9% | 40.6% |
| LSCC | $10.76B | 3932.5 | 2.7% | 0.59% | 0.44% | 68.2% |
| SITM | $9.29B | -205.3 | 61.2% | -13.1% | -3.8% | 53.6% |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat 16
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | $853M | $396M | $116M | $80M | |
| Cost of Revenue | $207M | $94M | $36M | $21M | |
| Gross Profit | $645M | $303M | $80M | $59M | |
| R&D Expense | $304M | $201M | $73M | $74M | |
| SG&A Expense | $88M | $94M | $16M | $21M | |
| Operating Expenses | $472M | $419M | $109M | $119M | |
| Operating Income | $173M | $-116M | $-29M | $-60M | |
| Interest Income | $45M | $34M | $7M | $3M | |
| Pretax Income | $218M | $-82M | $-23M | $-58M | |
| Income Tax | $-981.0K | $2M | $3M | $764.0K | |
| Net Income | $219M | $-83M | $-26M | $-58M | |
| EPS (Basic) | $1.32 | $-0.64 | $-0.71 | $-1.71 | |
| EPS (Diluted) | $1.22 | $-0.64 | $-0.71 | $-1.71 | |
| Shares (Basic) | 166,408,000 | 131,262,000 | 37,131,000 | 34,171,000 | |
| Shares (Diluted) | 179,551,000 | 131,262,000 | 37,131,000 | 34,171,000 | |
| EBITDA | $173M | $-116M | · | · |
Bilans 25
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Cash & Equivalents | $168M | $80M | $45M | · | |
| Receivables | $83M | $39M | $8M | · | |
| Inventory | $59M | $43M | $24M | · | |
| Prepaid Expense | $31M | $17M | $4M | · | |
| Other Current Assets | · | · | $686.0K | · | |
| Current Assets | $1.36B | $1.01B | $186M | · | |
| PP&E (Net) | $92M | $36M | $5M | · | |
| PP&E (Gross) | $104M | $41M | $7M | · | |
| Accum. Depreciation | $12M | $6M | $3M | · | |
| Goodwill | $19M | · | · | · | |
| Other Non-current Assets | $59M | $6M | $6M | · | |
| Total Assets | $1.53B | $1.05B | $196M | · | |
| Accounts Payable | $42M | $27M | $6M | · | |
| Accrued Liabilities | $91M | $60M | $29M | · | |
| Current Liabilities | $133M | $87M | $35M | · | |
| Capital Leases | $27M | $2M | $778.0K | · | |
| Other Non-current Liabilities | $35M | $3M | $4M | · | |
| Total Liabilities | $168M | $90M | $39M | · | |
| Common Stock | $17.0K | $16.0K | $4.0K | · | |
| Paid-in Capital | $1.35B | $1.17B | $27M | · | |
| Retained Earnings | $10M | $-209M | $-125M | · | |
| AOCI | $4M | $426.0K | $259.0K | · | |
| Stockholders' Equity | $1.36B | $965M | $-98M | $-85M | |
| Liabilities + Equity | $1.53B | $1.05B | $196M | · | |
| Shares Outstanding | 170,186,000 | 162,018,000 | 42,046,000 | 40,629,000 |
Przepływy pieniężne 12
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| D&A | $7M | $3M | $2M | · | |
| Stock-based Comp | $160M | $235M | $11M | $30M | |
| Deferred Tax | $19.0K | $0 | $0 | $0 | |
| Operating Cash Flow | $319M | $137M | $-13M | $-36M | |
| CapEx | $38M | $34M | $3M | $4M | |
| Investing Cash Flow | $-241M | $-758M | $-18M | $-91M | |
| Stock Repurchased | $0 | $1M | $210.0K | $313.0K | |
| Net Stock Activity | $0 | $-1M | · | · | |
| Financing Cash Flow | $10M | $656M | $-502.0K | $152M | |
| Net Change in Cash | $88M | $35M | $-31M | $25M | |
| Taxes Paid | $2M | $8M | $2M | $0 | |
| Free Cash Flow | $282M | $102M | · | · |
Rentowność 8
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Gross Margin | 75.7% | 76.4% | · | · | |
| Operating Margin | 20.3% | -29.3% | · | · | |
| Net Margin | 25.7% | -21.1% | · | · | |
| Pretax Margin | 25.6% | -20.6% | · | · | |
| EBITDA Margin | 20.3% | -29.3% | · | · | |
| ROA | 17.0% | -13.3% | · | · | |
| ROE | 17.5% | -9.0% | · | · | |
| ROIC | 12.8% | -12.3% | · | · |
Płynność i wypłacalność 2
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Current Ratio | 10.2 | 11.7 | · | · | |
| Quick Ratio | 1.9 | 1.4 | · | · |
Efektywność 3
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Asset Turnover | 0.7 | 0.6 | · | · | |
| Inventory Turnover | 4.1 | 2.8 | · | · | |
| Receivables Turnover | 14.0 | 16.8 | · | · |
Stopy Wzrostu 2
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue YoY | 115.1% | 242.2% | 45.0% | · | |
| Revenue CAGR 3Y | 120.2% | · | · | · |
Wycena (TTM) 10
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue TTM | $853M | $396M | · | · | |
| Net Income TTM | $219M | $-83M | · | · | |
| Market Cap | $28.31B | $21.46B | · | · | |
| P/E | 136.4 | -207.0 | · | · | |
| P/S | 33.2 | 54.2 | · | · | |
| P/B | 20.8 | 22.2 | · | · | |
| P / Tangible Book | 20.8 | 22.2 | · | · | |
| P / Cash Flow | 88.7 | 157.0 | · | · | |
| P / FCF | 100.5 | 209.5 | · | · | |
| Earnings Yield | 0.73% | -0.48% | · | · |
Rachunek zysków i strat 16
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $308M | $271M | $231M | $192M | $159M | $141M | $113M | $77M | $65M | $51M | $37M | $11M | $18M | |
| Cost of Revenue | $73M | $66M | $55M | $46M | $40M | $37M | $25M | $17M | $15M | $11M | $9M | $2M | $13M | |
| Gross Profit | $235M | $204M | $176M | $146M | $119M | $104M | $88M | $60M | $51M | $39M | $28M | $8M | $4M | |
| R&D Expense | $126M | $94M | $79M | $67M | $65M | $57M | $51M | $40M | $54M | $20M | $21M | $18M | $15M | |
| SG&A Expense | $26M | $24M | $22M | $20M | $22M | $25M | $23M | $22M | $24M | $5M | $4M | $3M | $4M | |
| Operating Expenses | $173M | $138M | $120M | $106M | $108M | $104M | $97M | $84M | $133M | $30M | $30M | $26M | $23M | |
| Operating Income | $62M | $67M | $55M | $40M | $11M | $144.0K | $-9M | $-24M | $-83M | $9M | $-2M | $-18M | $-19M | |
| Interest Income | $12M | $12M | $11M | $11M | $10M | $11M | $11M | $10M | $3M | $2M | $2M | $2M | $2M | |
| Pretax Income | $73M | $79M | $67M | $51M | $22M | $11M | $2M | $-14M | $-80M | $11M | $-253.0K | $-16M | $-17M | |
| Income Tax | $-7M | $34M | $-24M | $-560.0K | $-10M | $-14M | $10M | $-7M | $13M | $-4M | $3M | $4M | $123.0K | |
| Net Income | $80M | $45M | $91M | $51M | $32M | $25M | $-8M | $-8M | $-93M | $14M | $-3M | $-20M | $-17M | |
| EPS (Basic) | $0.47 | $0.28 | $0.54 | $0.31 | $0.19 | $1.23 | $-0.05 | $-0.05 | $-1.77 | $0.41 | $-0.08 | $-0.55 | $-0.49 | |
| EPS (Diluted) | $0.44 | $0.25 | $0.50 | $0.29 | $0.18 | $1.23 | $-0.05 | $-0.05 | $-1.77 | $0.41 | $-0.08 | $-0.55 | $-0.49 | |
| Shares (Basic) | 170,726,000 | -329,650,000 | 167,436,000 | 165,428,000 | 163,194,000 | -233,300,000 | 156,831,000 | 155,199,000 | 52,532,000 | -72,732,000 | 37,470,000 | 36,567,000 | 35,826,000 | |
| Shares (Diluted) | 181,157,000 | -357,296,000 | 180,631,000 | 178,100,000 | 178,116,000 | -233,300,000 | 156,831,000 | 155,199,000 | 52,532,000 | -72,732,000 | 37,470,000 | 36,567,000 | 35,826,000 | |
| EBITDA | $66M | · | $57M | $41M | $12M | · | $-9M | $-24M | $-83M | · | · | · | · |
Bilans 25
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $148M | $168M | $140M | $162M | $86M | $80M | $126M | $421M | $696M | · | · | · | · | |
| Receivables | $135M | $83M | $43M | $24M | $70M | $39M | $25M | $22M | $17M | · | · | · | · | |
| Inventory | $60M | $59M | $52M | $59M | $51M | $43M | $24M | $29M | $30M | · | · | · | · | |
| Prepaid Expense | $34M | $31M | $61M | $33M | $30M | $17M | $9M | $9M | $7M | · | · | · | · | |
| Other Current Assets | · | · | · | · | · | · | · | · | $835.0K | · | · | · | · | |
| Current Assets | $1.41B | $1.36B | $1.29B | $1.18B | $1.08B | $1.01B | $946M | $891M | $854M | · | · | · | · | |
| PP&E (Net) | $97M | $92M | $72M | $62M | $39M | $36M | $35M | $22M | $8M | · | · | · | · | |
| PP&E (Gross) | $113M | $104M | $81M | $69M | $46M | $41M | $40M | $26M | $11M | · | · | · | · | |
| Accum. Depreciation | $15M | $12M | $9M | $7M | $7M | $6M | $5M | $4M | $3M | · | · | · | · | |
| Goodwill | $88M | · | · | · | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $61M | $78M | $39M | $29M | $6M | $6M | $2M | $2M | $3M | · | · | · | · | |
| Total Assets | $1.66B | $1.53B | $1.40B | $1.27B | $1.12B | $1.05B | $983M | $916M | $865M | · | · | · | · | |
| Accounts Payable | $56M | $42M | $26M | $32M | $30M | $27M | $19M | $15M | $11M | · | · | · | · | |
| Accrued Liabilities | $69M | $91M | $75M | $75M | $48M | $60M | $69M | $49M | $34M | · | · | · | · | |
| Current Liabilities | $125M | $133M | $101M | $106M | $77M | $87M | $88M | $64M | $46M | · | · | · | · | |
| Capital Leases | $36M | $27M | $27M | $28M | · | $2M | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $40M | $35M | $28M | $29M | $3M | $3M | $5M | $6M | $11M | · | · | · | · | |
| Total Liabilities | $165M | $168M | $129M | $136M | $80M | $90M | $93M | $70M | $56M | · | · | · | · | |
| Common Stock | $17.0K | $17.0K | $17.0K | $17.0K | $16.0K | $16.0K | $16.0K | $16.0K | $16.0K | · | · | · | · | |
| Paid-in Capital | $1.40B | $1.35B | $1.30B | $1.26B | $1.22B | $1.17B | $1.12B | $1.07B | $1.03B | · | · | · | · | |
| Retained Earnings | $91M | $10M | $-35M | $-126M | $-177M | $-209M | $-234M | $-226M | $-218M | · | · | · | · | |
| AOCI | $-780.0K | $4M | $4M | $3M | $2M | $426.0K | $4M | $-352.0K | $-59.0K | · | · | · | · | |
| Stockholders' Equity | $1.49B | $1.36B | $1.27B | $1.14B | $1.04B | $965M | $890M | $845M | $809M | $-98M | · | · | · | |
| Liabilities + Equity | $1.66B | $1.53B | $1.40B | $1.27B | $1.12B | $1.05B | $983M | $916M | $865M | · | · | · | · | |
| Shares Outstanding | 171,277,000 | 170,186,000 | 168,903,000 | 166,211,000 | 164,907,000 | 162,018,000 | 158,561,000 | 156,656,000 | 155,471,000 | 42,046,000 | · | · | · |
Przepływy pieniężne 9
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $4M | · | $2M | $1M | $1M | · | $800.0K | $700.0K | $614.0K | · | · | · | · | |
| Stock-based Comp | $49M | $41M | $41M | $35M | $42M | $48M | $46M | $43M | $98M | $3M | $3M | $3M | $2M | |
| Other Non-cash | $-58M | · | · | · | $-65M | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $75M | $95M | $78M | $135M | $11M | $40M | $64M | $30M | $4M | $14M | $-334.0K | $-23M | $-4M | |
| CapEx | $8M | $19M | $12M | $2M | $5M | $15M | $17M | $-1M | $3M | $1M | $736.0K | $575.0K | $439.0K | |
| Investing Cash Flow | $-94M | $-73M | $-101M | $-64M | $-4M | $-91M | $-359M | $-302M | $-4M | $-6M | $-56M | $9M | $35M | |
| Financing Cash Flow | $82.0K | $4M | $952.0K | $5M | $386.0K | $6M | $952.0K | $-2M | $652M | $-1M | $644.0K | $-118.0K | $31.0K | |
| Net Change in Cash | $-19M | $26M | $-22M | $76M | $7M | $-46M | $-295M | $-275M | $651M | $7M | $-56M | $-14M | $32M | |
| Free Cash Flow | $67M | · | · | · | $6M | · | · | · | $228.0K | · | · | · | · |
Rentowność 8
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 76.3% | · | 76.2% | 75.8% | 74.9% | · | 77.7% | 77.9% | 77.4% | · | · | · | · | |
| Operating Margin | 20.1% | · | 24.0% | 20.7% | 7.1% | · | -7.9% | -31.7% | -127.1% | · | · | · | · | |
| Net Margin | 26.0% | · | 39.5% | 26.7% | 20.0% | · | -6.7% | -9.8% | -142.5% | · | · | · | · | |
| Pretax Margin | 23.8% | · | 29.0% | 26.4% | 13.6% | · | 1.8% | -18.3% | -123.2% | · | · | · | · | |
| EBITDA Margin | 21.2% | · | 24.7% | 21.4% | 7.8% | · | -7.9% | -31.7% | -127.1% | · | · | · | · | |
| ROA | 5.8% | · | 7.6% | 4.7% | 3.2% | · | -1.5% | -1.7% | -21.5% | · | · | · | · | |
| ROE | 6.3% | · | 8.4% | 5.2% | 3.4% | · | -1.7% | -1.8% | -23.0% | · | · | · | · | |
| ROIC | 4.5% | · | 5.9% | 3.5% | 1.6% | · | 3.8% | -1.5% | -11.9% | · | · | · | · |
Płynność i wypłacalność 2
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 11.3 | · | 12.8 | 11.1 | 13.9 | · | 10.7 | 13.9 | 18.7 | · | · | · | · | |
| Quick Ratio | 2.3 | · | 1.8 | 1.8 | 2.0 | · | 1.7 | 6.9 | 15.6 | · | · | · | · |
Efektywność 3
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | · | · | · | |
| Inventory Turnover | 1.3 | · | 1.4 | 1.1 | 1.0 | · | 2.1 | 1.2 | 1.0 | · | · | · | · | |
| Receivables Turnover | 3.0 | · | 6.8 | 8.2 | 3.7 | · | 8.9 | 6.9 | 7.8 | · | · | · | · |
Wycena (TTM) 10
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $890M | · | $695M | $541M | $415M | · | $292M | $190M | $131M | · | · | · | · | |
| Net Income TTM | $254M | · | $167M | $68M | $-76M | · | $-111M | $-124M | $-134M | · | · | · | · | |
| Market Cap | $18.77B | · | $33.07B | $15.03B | $9.84B | · | $8.31B | $9.48B | $11.53B | · | · | · | · | |
| P/E | 77.7 | · | 212.8 | 244.4 | -35.3 | · | -26.9 | -24.7 | -25.7 | · | · | · | · | |
| P/S | 21.1 | · | 47.6 | 27.8 | 23.7 | · | 28.4 | 50.0 | 88.4 | · | · | · | · | |
| P/B | 12.6 | · | 26.0 | 13.2 | 9.4 | · | 9.3 | 11.2 | 14.3 | · | · | · | · | |
| P / Tangible Book | 13.3 | · | 26.0 | 13.2 | 9.4 | · | 9.3 | 11.2 | 14.3 | · | · | · | · | |
| P / Cash Flow | 251.6 | · | · | · | 936.8 | · | · | · | 3158.4 | · | · | · | · | |
| P / FCF | 280.1 | · | · | · | 1649.6 | · | · | · | 50589.4 | · | · | · | · | |
| Earnings Yield | 1.3% | · | 0.47% | 0.41% | -2.8% | · | -3.7% | -4.0% | -3.9% | · | · | · | · |
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
Rachunek zysków i strat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | |
|---|---|---|---|---|
| Przychody | $853M | $396M | $116M | $80M |
| Marża Brutto % | 75.7% | 76.4% | — | — |
| Marża Operacyjna % | 20.3% | -29.3% | — | — |
| Zysk netto | $219M | $-83M | $-26M | $-58M |
| Rozwodniony EPS | $1.22 | $-0.64 | $-0.71 | $-1.71 |
Bilans
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | |
|---|---|---|---|---|
| Wskaźnik bieżący | 10.2 | 11.7 | — | — |
| Wskaźnik Szybkości | 1.9 | 1.4 | — | — |
Przepływy pieniężne
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | |
|---|---|---|---|---|
| Wolny przepływ pieniężny | $282M | $102M | — | — |
Najnowsze wiadomości Najnowsze nagłówki wspominające o tej firmie
- Astera Labs (ALAB) ma rozwiązać kluczowy problem w AI
- Oto dlaczego Artisan Mid Cap Fund zmniejszył swoje udziały w Astera Labs (ALAB)
- Czy Astera Labs. (ALAB) to najlepsza amerykańska spółka półprzewodnikowa do kupienia według analityków?
- ALAB, MRVL: Dlaczego największy zwycięzca umowy Amazona o wartości 100 miliardów dolarów z Anthropic może być tymi 2 akcjami
- Astera Labs (ALAB) otrzymuje dwucyfrową podwyżkę ceny docelowej przed wynikami, rośnie o 9%
- Akcje Astera Labs rosną dzięki dużej umowie Amazon-Anthropic. Czy warto kupić ALAB tutaj?
- Astera Labs Inc. (ALAB): Ulubieniec funduszy hedgingowych rozwiązuje wąskie gardła obliczeniowe
- Astera Labs (ALAB) przewiduje wysoki, dwucyfrowy wzrost, wzrasta o 11,9% więcej
- Astera Labs (ALAB) oczekuje 'wysokiego wzrostu w dwucyfrowych cyfrach', wzrost o 27%
- Astera Labs (ALAB) Oferta sygnalizuje wzrost płynności i zainteresowanie instytucjonalne
Sygnały transakcyjne Ostatnie sygnały kupna/sprzedaży z ceną wejścia i wskaźnikiem ryzyka/zysku
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
📊
Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.